Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Stanford University
ViroMissile, Inc.
Replimune Inc.
Tizona Therapeutics, Inc
MacroGenics
Fusion Pharmaceuticals Inc.
University of Southern California
OncoNano Medicine, Inc.
Abramson Cancer Center at Penn Medicine
AstraZeneca
Actym Therapeutics, Inc.
University of Virginia
Eli Lilly and Company
Shandong Boan Biotechnology Co., Ltd
Mayo Clinic
Columbia University
Tvardi Therapeutics, Incorporated
Turnstone Biologics, Corp.
Eli Lilly and Company
NGM Biopharmaceuticals, Inc
Eli Lilly and Company
NantBioScience, Inc.
Gene Surgery LLC
Pfizer
DNAtrix, Inc.
NGM Biopharmaceuticals, Inc
Celldex Therapeutics
Eisai Inc.
National Cancer Institute (NCI)
Atreca, Inc.
Oncorus, Inc.
Fate Therapeutics
Pfizer
Prelude Therapeutics
Herlev Hospital
Quadriga Biosciences, Inc.
Genzada Pharmaceuticals USA, Inc.
Xencor, Inc.
Provectus Pharmaceuticals
Ludwig Institute for Cancer Research
Imperial College London
Incyte Corporation
MacroGenics
Seagen Inc.
Lumos Pharma
Abramson Cancer Center at Penn Medicine
Celgene
University of Wisconsin, Madison
AstraZeneca